TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/21/23 21:05 | 4/20/23 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dagnon Terry | NJ | O | Chief Op | S | -590 | 1.14 | 0 | -520 | -44 | 653 | D | ||||||||||||||
6/23/22 17:08 | 6/21/22 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dagnon Terry | NJ | O | COO | P | 11 | 1.05 | 0 | 10 | 1 | 1,173 | D | ||||||||||||||
12/6/21 17:26 | 12/6/21 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dagnon Terry | NJ | O | COO | P | 35 | 1.38 | 0 | 25 | 2 | 1,163 | D | ||||||||||||||
12/3/21 16:32 | 12/3/21 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dagnon Terry | NJ | O | COO | P | 14 | 1.42 | 0 | 10 | 1 | 1,138 | D | ||||||||||||||
2/25/21 20:51 | 2/23/21 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dagnon Terry | NJ | O | COO | S | -33 | 2.09 | 0 | -16 | -1 | 1,128 | D | ||||||||||||||
2/17/21 21:13 | 2/12/21 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dagnon Terry | NJ | O | COO | S | -162 | 2.55 | 0 | -64 | -5 | 1,144 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |